GSTC OTC
GlobeStar Therapeutics Corporation
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -96.5%
5Y: -99.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.0001-0.0001
Volume300,000
Avg Volume85
Beta1.11
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJames C. Katzaroff
SectorHealthcare
IndustryBiotechnology
IPO Date2011-09-26
Websiteglobestartherapeutics.com
1280 Lexington Avenue
New York, NY 10028
US
New York, NY 10028
US
206 451 1970
About GlobeStar Therapeutics Corporation
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| KATZAROFF JAMES C | J-Other | 7,042,253 | $0.01 | 2023-04-03 |
| KATZAROFF JAMES C | J-Other | 70,422,535 | $0.01 | 2023-04-03 |
| KATZAROFF JAMES C | A-Award | 35,000,000 | $0.01 | 2023-02-24 |
| Chicoski Robert | 0 | — | 2022-11-23 | |
| KATZAROFF JAMES C | A-Award | 30,000,000 | $0.03 | 2021-05-12 |